FNDC5 and ovarian cancer: Protein expression of FNDC5/irisin was higher in breast and ovarian cancer tissue specimens [16], as well as in oncocytic papillary thyroid carcinoma [34] and in a series of gastrointestinal cancers compared to nonneoplastic tissues [35].